Position in EW
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$159,869,868
-$345,289,833 QoQ
Shares Held
1,996,377
-66.3% QoQ
Ownership
0.347%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EW Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $1,200,961,606 across 58 Medical Devices names. EW ranks #4 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
3,611,020 | $226,591,504 | |
| 2 | SYK |
Stryker Corp
|
630,236 | $207,089,246 | |
| 3 | ABT |
Abbott Laboratories
|
2,010,938 | $206,463,003 | |
| 4 | EW |
Edwards Lifesciences Corp
This page
|
1,996,377 | $159,869,868 | |
| 5 | PODD |
Insulet Corp
|
606,482 | $127,264,182 | |
| 6 | GMED |
Globus Medical Inc
|
562,630 | $48,476,200 | |
| 7 | TNDM |
Tandem Diabetes Care Inc
|
1,442,472 | $27,652,186 | |
| 8 | HAE |
Haemonetics Corp
|
320,010 | $18,035,762 |
All Filings in EW
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $159,869,868 | 1,996,377 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $505,159,701 | 5,925,627 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $277,366,626 | 3,566,499 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $539,303,232 | 6,895,579 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $219,663,033 | 3,030,671 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $430,367,407 | 5,813,419 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $246,391,944 | 3,733,777 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $6,896,898 | 74,666 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $17,104,666 | 178,994 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $7,855,351 | 103,021 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $123,720,015 | 1,785,797 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $430,497,310 | 4,563,737 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $410,820,302 | 4,965,796 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $309,931,954 | 4,154,027 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $290,222,339 | 3,512,312 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $124,843,850 | 1,312,902 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $50,563,329 | 429,522 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $23,411,757 | 180,716 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $1,099,382 | 9,711 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $7,989,292 | 95,520 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $3,044,733 | 38,145 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,733,991 | 39,560 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $870,543 | 13,846 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||